Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 102 | 2020 | 830 | 15.330 |
Why?
|
| Tobacco Use Disorder | 72 | 2020 | 245 | 14.200 |
Why?
|
| Adolescent Behavior | 51 | 2020 | 188 | 6.620 |
Why?
|
| Smoking Prevention | 37 | 2018 | 162 | 5.160 |
Why?
|
| Substance Withdrawal Syndrome | 18 | 2016 | 117 | 4.450 |
Why?
|
| Behavior, Addictive | 20 | 2020 | 75 | 4.020 |
Why?
|
| Commerce | 19 | 2020 | 59 | 3.850 |
Why?
|
| Personal Autonomy | 17 | 2015 | 66 | 3.830 |
Why?
|
| Nicotine | 19 | 2017 | 111 | 3.240 |
Why?
|
| Adolescent | 114 | 2020 | 5939 | 3.220 |
Why?
|
| Tobacco Products | 10 | 2020 | 75 | 3.010 |
Why?
|
| Smoking Cessation | 31 | 2020 | 537 | 2.690 |
Why?
|
| Tobacco Industry | 13 | 2014 | 21 | 2.550 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2016 | 57 | 1.870 |
Why?
|
| Minors | 6 | 2020 | 9 | 1.830 |
Why?
|
| Male | 94 | 2020 | 27765 | 1.400 |
Why?
|
| Female | 93 | 2020 | 31093 | 1.310 |
Why?
|
| Humans | 138 | 2020 | 59799 | 1.290 |
Why?
|
| Psychometrics | 16 | 2016 | 357 | 1.220 |
Why?
|
| Child | 42 | 2016 | 4324 | 1.210 |
Why?
|
| Students | 7 | 2016 | 208 | 1.010 |
Why?
|
| Craving | 5 | 2016 | 35 | 1.000 |
Why?
|
| Surveys and Questionnaires | 20 | 2018 | 2601 | 0.990 |
Why?
|
| Nicotinic Agonists | 5 | 2015 | 39 | 0.930 |
Why?
|
| Brain | 9 | 2020 | 1492 | 0.920 |
Why?
|
| Smokers | 4 | 2020 | 112 | 0.850 |
Why?
|
| State Government | 3 | 2018 | 32 | 0.850 |
Why?
|
| Law Enforcement | 4 | 2011 | 27 | 0.830 |
Why?
|
| Health Education | 6 | 2008 | 184 | 0.800 |
Why?
|
| Drug and Narcotic Control | 5 | 2011 | 30 | 0.790 |
Why?
|
| Receptors, Nicotinic | 3 | 2020 | 67 | 0.790 |
Why?
|
| Water Pipe Smoking | 5 | 2020 | 9 | 0.780 |
Why?
|
| Family | 3 | 2016 | 223 | 0.780 |
Why?
|
| United States | 31 | 2020 | 7568 | 0.750 |
Why?
|
| Attitude to Health | 5 | 2011 | 279 | 0.690 |
Why?
|
| Plants, Toxic | 6 | 1999 | 12 | 0.680 |
Why?
|
| Young Adult | 15 | 2020 | 4363 | 0.660 |
Why?
|
| Counseling | 6 | 2015 | 352 | 0.660 |
Why?
|
| Child Behavior | 10 | 2010 | 69 | 0.650 |
Why?
|
| Substance-Related Disorders | 5 | 2020 | 691 | 0.630 |
Why?
|
| Parents | 5 | 2015 | 387 | 0.630 |
Why?
|
| Population Surveillance | 2 | 2018 | 205 | 0.620 |
Why?
|
| Government Programs | 1 | 2018 | 20 | 0.620 |
Why?
|
| Motivation | 7 | 2016 | 270 | 0.620 |
Why?
|
| Massachusetts | 19 | 2015 | 2111 | 0.600 |
Why?
|
| Adult | 33 | 2016 | 15879 | 0.580 |
Why?
|
| Health Promotion | 6 | 2018 | 490 | 0.560 |
Why?
|
| Health Surveys | 8 | 2011 | 311 | 0.550 |
Why?
|
| Psychology, Adolescent | 6 | 2009 | 26 | 0.550 |
Why?
|
| Prevalence | 8 | 2016 | 1288 | 0.530 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 7 | 0.510 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 22 | 0.510 |
Why?
|
| Receptors, Opioid, mu | 1 | 2015 | 15 | 0.510 |
Why?
|
| Government Regulation | 3 | 2011 | 44 | 0.510 |
Why?
|
| Tobacco, Smokeless | 3 | 2011 | 8 | 0.500 |
Why?
|
| Marketing of Health Services | 3 | 2001 | 23 | 0.490 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2010 | 122 | 0.490 |
Why?
|
| Advisory Committees | 1 | 2015 | 107 | 0.470 |
Why?
|
| Reproducibility of Results | 11 | 2015 | 1559 | 0.470 |
Why?
|
| International Classification of Diseases | 3 | 2010 | 143 | 0.470 |
Why?
|
| Parietal Lobe | 1 | 2014 | 29 | 0.450 |
Why?
|
| Asthma | 3 | 2016 | 419 | 0.450 |
Why?
|
| Behavior Therapy | 1 | 2015 | 163 | 0.450 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 57 | 0.440 |
Why?
|
| Time Factors | 13 | 2018 | 3589 | 0.430 |
Why?
|
| Longitudinal Studies | 10 | 2020 | 1231 | 0.430 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 2488 | 0.410 |
Why?
|
| Schools | 9 | 2020 | 156 | 0.400 |
Why?
|
| Inhalation Exposure | 1 | 2012 | 57 | 0.390 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2012 | 34 | 0.390 |
Why?
|
| Pediatrics | 3 | 2015 | 268 | 0.380 |
Why?
|
| Disease Progression | 2 | 2016 | 1052 | 0.370 |
Why?
|
| Habits | 1 | 2011 | 21 | 0.370 |
Why?
|
| Risk Factors | 13 | 2015 | 5037 | 0.370 |
Why?
|
| Age Factors | 9 | 2014 | 1521 | 0.370 |
Why?
|
| Benzazepines | 1 | 2011 | 21 | 0.370 |
Why?
|
| Maze Learning | 1 | 2011 | 52 | 0.370 |
Why?
|
| Drug Tolerance | 2 | 2011 | 28 | 0.370 |
Why?
|
| Child Welfare | 3 | 2008 | 54 | 0.370 |
Why?
|
| Impulsive Behavior | 1 | 2011 | 28 | 0.360 |
Why?
|
| Quinoxalines | 1 | 2011 | 35 | 0.360 |
Why?
|
| Mental Recall | 3 | 2014 | 94 | 0.350 |
Why?
|
| Guideline Adherence | 3 | 2009 | 298 | 0.350 |
Why?
|
| Primary Health Care | 1 | 2015 | 659 | 0.330 |
Why?
|
| New Zealand | 4 | 2016 | 34 | 0.330 |
Why?
|
| Psychological Theory | 2 | 2015 | 26 | 0.320 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 33 | 0.320 |
Why?
|
| Prospective Studies | 11 | 2016 | 3110 | 0.310 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 387 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 571 | 0.300 |
Why?
|
| Motor Activity | 1 | 2011 | 343 | 0.300 |
Why?
|
| Motion Pictures | 1 | 2007 | 11 | 0.290 |
Why?
|
| Social Control, Formal | 3 | 2001 | 20 | 0.280 |
Why?
|
| Ganglionic Stimulants | 1 | 2007 | 5 | 0.280 |
Why?
|
| Health Behavior | 1 | 2010 | 472 | 0.280 |
Why?
|
| Universities | 1 | 2008 | 152 | 0.270 |
Why?
|
| Personality Inventory | 1 | 2006 | 50 | 0.270 |
Why?
|
| Marketing | 3 | 2014 | 18 | 0.270 |
Why?
|
| Physician's Role | 4 | 2003 | 120 | 0.260 |
Why?
|
| Middle Aged | 12 | 2016 | 16397 | 0.260 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 118 | 0.250 |
Why?
|
| Tobacco Use Cessation | 2 | 2008 | 30 | 0.250 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 150 | 0.250 |
Why?
|
| Odds Ratio | 7 | 2011 | 773 | 0.250 |
Why?
|
| Receptors, Cholinergic | 1 | 2005 | 22 | 0.240 |
Why?
|
| Menthol | 2 | 2017 | 5 | 0.240 |
Why?
|
| Manifest Anxiety Scale | 1 | 2004 | 2 | 0.240 |
Why?
|
| Social Class | 2 | 2014 | 123 | 0.230 |
Why?
|
| Peer Group | 3 | 2011 | 96 | 0.230 |
Why?
|
| Taxes | 3 | 2000 | 6 | 0.230 |
Why?
|
| Models, Neurological | 1 | 2005 | 81 | 0.230 |
Why?
|
| Self-Assessment | 1 | 2004 | 55 | 0.230 |
Why?
|
| Rats | 5 | 2017 | 1918 | 0.230 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 47 | 0.230 |
Why?
|
| Nurse's Role | 2 | 2011 | 121 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 2049 | 0.230 |
Why?
|
| Cyprus | 2 | 2016 | 2 | 0.220 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 1460 | 0.220 |
Why?
|
| Income | 2 | 2003 | 160 | 0.220 |
Why?
|
| Locomotion | 3 | 2017 | 110 | 0.220 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 80 | 0.220 |
Why?
|
| Risk Assessment | 6 | 2014 | 1918 | 0.210 |
Why?
|
| Adolescent Medicine | 1 | 2003 | 6 | 0.210 |
Why?
|
| Cues | 3 | 2015 | 75 | 0.210 |
Why?
|
| Social Environment | 3 | 2015 | 94 | 0.210 |
Why?
|
| Injections, Subcutaneous | 2 | 2015 | 71 | 0.210 |
Why?
|
| Pleasure | 2 | 2014 | 13 | 0.210 |
Why?
|
| Seasons | 1 | 2003 | 130 | 0.210 |
Why?
|
| Proportional Hazards Models | 3 | 2010 | 672 | 0.210 |
Why?
|
| Arousal | 2 | 2014 | 42 | 0.210 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 279 | 0.200 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 785 | 0.200 |
Why?
|
| Lebanon | 5 | 2020 | 10 | 0.200 |
Why?
|
| Causality | 2 | 2016 | 55 | 0.200 |
Why?
|
| Factor Analysis, Statistical | 3 | 2015 | 105 | 0.200 |
Why?
|
| Brain Mapping | 3 | 2016 | 228 | 0.180 |
Why?
|
| Anxiety | 1 | 2004 | 398 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2009 | 2461 | 0.180 |
Why?
|
| Child, Preschool | 3 | 2016 | 1843 | 0.180 |
Why?
|
| Facility Regulation and Control | 1 | 2000 | 3 | 0.180 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2000 | 7 | 0.180 |
Why?
|
| Industry | 3 | 1996 | 61 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2079 | 0.180 |
Why?
|
| Sudden Infant Death | 2 | 2004 | 20 | 0.180 |
Why?
|
| Logistic Models | 5 | 2016 | 1252 | 0.180 |
Why?
|
| Incidence | 3 | 2009 | 1245 | 0.180 |
Why?
|
| Age Distribution | 3 | 2015 | 261 | 0.170 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 16 | 0.170 |
Why?
|
| Marijuana Use | 1 | 2020 | 16 | 0.170 |
Why?
|
| Aged | 7 | 2016 | 13461 | 0.170 |
Why?
|
| Private Sector | 1 | 1999 | 14 | 0.170 |
Why?
|
| Interviews as Topic | 3 | 2007 | 494 | 0.170 |
Why?
|
| Cluster Analysis | 2 | 2016 | 251 | 0.170 |
Why?
|
| Australia | 2 | 2010 | 94 | 0.170 |
Why?
|
| Vaping | 1 | 2020 | 43 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6041 | 0.160 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 71 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2001 | 209 | 0.160 |
Why?
|
| Colorado | 1 | 2018 | 19 | 0.160 |
Why?
|
| Research Design | 2 | 2015 | 569 | 0.160 |
Why?
|
| Infant | 4 | 2012 | 1527 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 163 | 0.160 |
Why?
|
| Age of Onset | 2 | 2008 | 171 | 0.150 |
Why?
|
| Quebec | 2 | 2009 | 12 | 0.150 |
Why?
|
| Sex Distribution | 2 | 2008 | 254 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 2341 | 0.140 |
Why?
|
| Neural Pathways | 2 | 2016 | 97 | 0.140 |
Why?
|
| Perception | 2 | 2009 | 179 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2017 | 80 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 417 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1097 | 0.140 |
Why?
|
| Public Policy | 2 | 1999 | 41 | 0.140 |
Why?
|
| Public Health | 2 | 2003 | 180 | 0.140 |
Why?
|
| Visual Cortex | 1 | 2016 | 27 | 0.130 |
Why?
|
| Tobacco, Waterpipe | 1 | 2016 | 8 | 0.130 |
Why?
|
| Animals | 8 | 2017 | 19718 | 0.130 |
Why?
|
| Relaxation | 2 | 2007 | 6 | 0.130 |
Why?
|
| Mississippi | 2 | 2015 | 33 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 925 | 0.130 |
Why?
|
| Legislation as Topic | 3 | 1996 | 11 | 0.130 |
Why?
|
| Corpus Striatum | 1 | 2016 | 96 | 0.130 |
Why?
|
| Minisatellite Repeats | 1 | 2015 | 6 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2010 | 486 | 0.130 |
Why?
|
| Stress, Psychological | 3 | 2011 | 450 | 0.130 |
Why?
|
| Binge Drinking | 1 | 2016 | 29 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 402 | 0.120 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 51 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 300 | 0.120 |
Why?
|
| Sex Factors | 3 | 2007 | 968 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 194 | 0.120 |
Why?
|
| Legislation, Drug | 1 | 2014 | 18 | 0.120 |
Why?
|
| Restaurants | 2 | 2018 | 28 | 0.120 |
Why?
|
| Alleles | 1 | 2015 | 422 | 0.110 |
Why?
|
| Genotype | 1 | 2015 | 640 | 0.110 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 446 | 0.110 |
Why?
|
| Communication | 2 | 2015 | 556 | 0.110 |
Why?
|
| Corpus Callosum | 1 | 2013 | 41 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2013 | 66 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 454 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 798 | 0.100 |
Why?
|
| Netherlands | 1 | 2012 | 23 | 0.100 |
Why?
|
| Ethics, Pharmacy | 1 | 1992 | 3 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 638 | 0.100 |
Why?
|
| Academies and Institutes | 1 | 1992 | 22 | 0.100 |
Why?
|
| Cartoons as Topic | 1 | 1991 | 1 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 1030 | 0.100 |
Why?
|
| Pharmacies | 1 | 1992 | 36 | 0.100 |
Why?
|
| Depression | 3 | 2016 | 866 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2012 | 1307 | 0.100 |
Why?
|
| Indians, North American | 1 | 2011 | 26 | 0.100 |
Why?
|
| School Nursing | 1 | 2011 | 26 | 0.090 |
Why?
|
| Reference Values | 2 | 2011 | 321 | 0.090 |
Why?
|
| Florida | 1 | 2011 | 40 | 0.090 |
Why?
|
| Prisons | 1 | 2012 | 114 | 0.090 |
Why?
|
| Varenicline | 1 | 2011 | 11 | 0.090 |
Why?
|
| Data Collection | 2 | 2005 | 385 | 0.090 |
Why?
|
| Greece | 1 | 2010 | 3 | 0.090 |
Why?
|
| Bias | 2 | 2002 | 106 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 148 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 95 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2012 | 165 | 0.090 |
Why?
|
| Otitis Media | 2 | 2004 | 12 | 0.090 |
Why?
|
| Exploratory Behavior | 2 | 2008 | 33 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2011 | 165 | 0.090 |
Why?
|
| United Kingdom | 1 | 2010 | 70 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 229 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 1995 | 392 | 0.090 |
Why?
|
| Trust | 1 | 2011 | 69 | 0.090 |
Why?
|
| Manuals as Topic | 1 | 2009 | 5 | 0.090 |
Why?
|
| Research | 1 | 2011 | 190 | 0.090 |
Why?
|
| Physicians, Family | 2 | 2003 | 75 | 0.080 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2009 | 8 | 0.080 |
Why?
|
| New South Wales | 1 | 2009 | 3 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2011 | 5204 | 0.080 |
Why?
|
| Linear Models | 2 | 2011 | 423 | 0.080 |
Why?
|
| Imagination | 1 | 2008 | 7 | 0.080 |
Why?
|
| Personality Assessment | 1 | 2008 | 21 | 0.080 |
Why?
|
| Truth Disclosure | 1 | 2008 | 54 | 0.080 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 20 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 63 | 0.070 |
Why?
|
| Internet | 1 | 2011 | 460 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 172 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 207 | 0.070 |
Why?
|
| Cotinine | 1 | 2007 | 18 | 0.070 |
Why?
|
| Rats, Inbred WKY | 2 | 2017 | 11 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 50 | 0.070 |
Why?
|
| Life Style | 1 | 2009 | 330 | 0.070 |
Why?
|
| Endorphins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 157 | 0.070 |
Why?
|
| Nonprescription Drugs | 1 | 2007 | 18 | 0.070 |
Why?
|
| Mass Media | 2 | 2006 | 30 | 0.070 |
Why?
|
| Saliva | 1 | 2007 | 96 | 0.070 |
Why?
|
| Intention | 1 | 2007 | 66 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2007 | 147 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2008 | 192 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2008 | 137 | 0.070 |
Why?
|
| Alcoholism | 1 | 1990 | 308 | 0.070 |
Why?
|
| Narcotics | 1 | 2007 | 51 | 0.070 |
Why?
|
| Risk | 1 | 2007 | 374 | 0.070 |
Why?
|
| Serotonin | 1 | 2007 | 63 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2007 | 99 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2007 | 98 | 0.070 |
Why?
|
| Dopamine | 1 | 2007 | 102 | 0.070 |
Why?
|
| Consensus | 1 | 2007 | 195 | 0.060 |
Why?
|
| Attitude | 2 | 2003 | 101 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2006 | 183 | 0.060 |
Why?
|
| Financing, Organized | 1 | 2005 | 16 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 14 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 151 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2005 | 32 | 0.060 |
Why?
|
| Hospitalization | 1 | 2012 | 1295 | 0.060 |
Why?
|
| Recurrence | 1 | 2006 | 581 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2011 | 487 | 0.060 |
Why?
|
| Homeostasis | 1 | 2007 | 343 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1034 | 0.060 |
Why?
|
| Dizziness | 1 | 2004 | 17 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 743 | 0.060 |
Why?
|
| Intelligence | 1 | 2004 | 56 | 0.060 |
Why?
|
| Nursing Methodology Research | 1 | 2003 | 52 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2003 | 44 | 0.050 |
Why?
|
| Texas | 1 | 2003 | 54 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 109 | 0.050 |
Why?
|
| Personality | 1 | 2003 | 25 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 392 | 0.050 |
Why?
|
| Pregnancy | 2 | 2004 | 2359 | 0.050 |
Why?
|
| Self Report | 2 | 2016 | 368 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2003 | 159 | 0.050 |
Why?
|
| Interview, Psychological | 1 | 2002 | 77 | 0.050 |
Why?
|
| Politics | 1 | 2002 | 31 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2002 | 77 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 273 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2001 | 14 | 0.050 |
Why?
|
| Smoking Water Pipes | 1 | 2020 | 6 | 0.050 |
Why?
|
| Management Audit | 1 | 2000 | 3 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2000 | 45 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2001 | 225 | 0.040 |
Why?
|
| Crime | 1 | 2000 | 63 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 301 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 556 | 0.040 |
Why?
|
| Chewing Gum | 2 | 2007 | 7 | 0.040 |
Why?
|
| Rats, Inbred SHR | 1 | 2016 | 5 | 0.030 |
Why?
|
| Adenoidectomy | 1 | 1996 | 4 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 1996 | 9 | 0.030 |
Why?
|
| Middle Ear Ventilation | 1 | 1996 | 4 | 0.030 |
Why?
|
| Fires | 1 | 1996 | 12 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 25 | 0.030 |
Why?
|
| Self Concept | 1 | 2016 | 103 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 35 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 53 | 0.030 |
Why?
|
| Office Visits | 1 | 1996 | 41 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 90 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1995 | 93 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 14 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1995 | 19 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2008 | 577 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 1995 | 30 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 58 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1996 | 206 | 0.030 |
Why?
|
| Health Policy | 1 | 1996 | 185 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 150 | 0.030 |
Why?
|
| Cough | 1 | 1996 | 182 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1091 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 59 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1996 | 241 | 0.030 |
Why?
|
| Pneumonia | 1 | 1996 | 270 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 68 | 0.030 |
Why?
|
| Pattern Recognition, Visual | 1 | 1991 | 37 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 256 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 1992 | 220 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 372 | 0.020 |
Why?
|
| Decision Making | 1 | 1992 | 393 | 0.020 |
Why?
|
| Role Playing | 1 | 1988 | 7 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 32 | 0.020 |
Why?
|
| Tablets | 1 | 2007 | 11 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 27 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1990 | 1059 | 0.020 |
Why?
|
| Ethanol | 1 | 1990 | 307 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 217 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 309 | 0.020 |
Why?
|
| Social Behavior | 1 | 2005 | 88 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2005 | 201 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 31 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2003 | 54 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 36 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 178 | 0.010 |
Why?
|
| Family Practice | 1 | 2003 | 206 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 454 | 0.010 |
Why?
|
| Focus Groups | 1 | 2002 | 293 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 442 | 0.010 |
Why?
|
| Emotions | 1 | 2002 | 217 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 709 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 5147 | 0.010 |
Why?
|